Has Michael Martyak, MD received payments from drug or device companies?

Yes. Drug and device makers reported $46,543 in general payments to Michael Martyak, MD across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Martyak, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Martyak, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Martyak, MD

Surgical Critical Care · Norfolk, VANPI 1255621900

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.4%), consulting fees and education — rather than concentrated in one kind of arrangement. Teleflex LLC accounts for 61.5% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2023 at $12,803 and has fallen 60.5% since, to $5,056 in 2025. Among surgical critical care clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,543in general payments, 2019–2025

Across 117 payments — averaging $397.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$29K
Intuitive Surgical$10K
Arrow International, Inc.$4K
Davol Inc.$1K
Medline Industries LP$546
Access Pro Medical, LLC$318
plus $2K from 19 others

What the payments were for

Consulting fees$14,49631%
Speaking & faculty fees$16,92536%
Travel & lodging$2,9966%
Food & beverage$4,3319%
Education$7,79517%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	29	$28,636
Intuitive Surgical	31	$10,019
Arrow International, Inc.	1	$4,050
Davol Inc.	12	$1,056
Medline Industries LP	1	$546
Access Pro Medical, LLC	3	$318
Integra Lifesciences Corporation	9	$287
Polynovo North America LLC	3	$233
Avita Medical Americas, LLC	2	$171
W. L. Gore & Associates, Inc.	2	$164
Baxter Healthcare	2	$144
Johnson & Johnson	1	$143
Acell, Inc.	3	$122
Pacira Pharmaceuticals Incorporated	1	$111
CLR Medical, Inc.	2	$110
Molli Surgical (US) Inc	1	$83
TELA Bio, Inc.	1	$74
Takeda Pharmaceuticals U.S.A., Inc.	3	$58
Kerecis Limited	2	$55
Stryker	2	$54
Medtronic	2	$32
Z-medica, LLC	1	$30
Avanos Medical	1	$17
Atricure, Inc.	1	$16
Coopersurgical, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,543 in reported general payments places this provider in the 95th percentile of 60 surgical critical care providers in Virginia.

See all surgical critical care providers in Virginia →

Medicare billing

Part B allowed, 2024

$127,808

Medicare patients

355

Services billed

789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	18	$29

Paid to pharmacies, not to this prescriber.

Other surgical critical care in Norfolk

Lunzy BrittNorfolk$33K
Alexa ShawNorfolk$12K
Jessica BurgessNorfolk$3K
Rafael Tolentino AquinoNorfolk$1K
Laquanda KnowlinNorfolk$1K
Brian KingNorfolk$116
Jeffrey LittRichmond$54K
George KasotakisFairfax$25K
Mack DrakeRichmond$21K
Alexander EvansSalem$16K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →